At a glance
- Originator Pfizer
- Class Antidepressants; Anxiolytics; Small molecules
- Mechanism of Action Corticotropin-releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder
Most Recent Events
- 21 Jul 2000 Profile reviewed but no significant changes made
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 08 Dec 1998 Preclinical development for Anxiety disorders in USA (Unknown route)